Plasma Levels of Fatty Acid-Binding Protein 4, Retinol-Binding Protein 4, High-Molecular-Weight Adiponectin, and Cardiovascular Mortality Among Men With Type 2 Diabetes: A 22-Year Prospective Study

Arterioscler Thromb Vasc Biol. 2016 Nov;36(11):2259-2267. doi: 10.1161/ATVBAHA.116.308320. Epub 2016 Sep 8.

Abstract

Objective: To examine select adipokines, including fatty acid-binding protein 4, retinol-binding protein 4, and high-molecular-weight (HMW) adiponectin in relation to cardiovascular disease (CVD) mortality among patients with type 2 diabetes mellitus.

Approach and results: Plasma levels of fatty acid-binding protein 4, retinol-binding protein 4, and HMW adiponectin were measured in 950 men with type 2 diabetes mellitus in the Health Professionals Follow-up Study. After an average of 22 years of follow-up (1993-2015), 580 deaths occurred, of whom 220 died of CVD. After multivariate adjustment for covariates, higher levels of fatty acid-binding protein 4 were significantly associated with a higher CVD mortality: comparing extreme tertiles, the hazard ratio and 95% confidence interval of CVD mortality was 1.78 (1.22-2.59; P trend=0.001). A positive association was also observed for HMW adiponectin: the hazard ratio (95% confidence interval) was 2.07 (1.42-3.06; P trend=0.0002), comparing extreme tertiles, whereas higher retinol-binding protein 4 levels were nonsignificantly associated with a decreased CVD mortality with an hazard ratio (95% confidence interval) of 0.73 (0.50-1.07; P trend=0.09). A Mendelian randomization analysis suggested that the causal relationships of HMW adiponectin and retinol-binding protein 4 would be directionally opposite to those observed based on the biomarkers, although none of the Mendelian randomization associations achieved statistical significance.

Conclusions: These data suggest that higher levels of fatty acid-binding protein 4 and HMW adiponectin are associated with elevated CVD mortality among men with type 2 diabetes mellitus. Biological mechanisms underlying these observations deserve elucidation, but the associations of HMW adiponectin may partially reflect altered adipose tissue functionality among patients with type 2 diabetes mellitus.

Keywords: adipokines; adiponectin; cardiovascular disease; fatty acid–binding proteins; heart failure.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin / blood*
  • Adiponectin / genetics
  • Adult
  • Aged
  • Biomarkers / blood
  • Cardiovascular Diseases / blood*
  • Cardiovascular Diseases / diagnosis
  • Cardiovascular Diseases / genetics
  • Cardiovascular Diseases / mortality*
  • Cause of Death
  • Chi-Square Distribution
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / diagnosis
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / mortality*
  • Fatty Acid-Binding Proteins / blood*
  • Fatty Acid-Binding Proteins / genetics
  • Genetic Predisposition to Disease
  • Humans
  • Linear Models
  • Male
  • Mendelian Randomization Analysis
  • Middle Aged
  • Molecular Weight
  • Multivariate Analysis
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Proportional Hazards Models
  • Prospective Studies
  • Retinol-Binding Proteins, Plasma / analysis*
  • Retinol-Binding Proteins, Plasma / genetics
  • Risk Assessment
  • Risk Factors
  • Sex Factors
  • Time Factors
  • United States / epidemiology

Substances

  • ADIPOQ protein, human
  • Adiponectin
  • Biomarkers
  • FABP4 protein, human
  • Fatty Acid-Binding Proteins
  • RBP4 protein, human
  • Retinol-Binding Proteins, Plasma